Copyright
©The Author(s) 2025.
World J Cardiol. Jul 26, 2025; 17(7): 109787
Published online Jul 26, 2025. doi: 10.4330/wjc.v17.i7.109787
Published online Jul 26, 2025. doi: 10.4330/wjc.v17.i7.109787
Table 2 Comparative table of clinical characteristics of acute myocardial infarction complicated by ventricular septal rupture
Clinical factors | Clinical manifestations | Diagnostic methods | Risk factors | Prevalence (%) | Treatment options | Ref. |
Gender | The proportion of females was significantly higher than that in the control group (62.5% vs 36.4%) | Retrospective cohort analysis | Female is an independent risk factor | 62.5 (VSR group) | Gender does not affect treatment selection, but women require closer hemodynamic monitoring | [6,105] |
Age | Average age 66.85 years (VSR group) vs 60.79 years (control group) | Analysis of clinical data | Advanced age (> 65 years) significantly increases the risk | - | Elderly patients should be prioritized for interventional or surgical procedures | [6,105] |
Inflammatory markers | CRP, D-dimer levels are significantly elevated | Serological testing (CRP, D-dimer) | Inflammatory response exacerbates myocardial necrosis | - | Anti-inflammatory therapy (such as glucocorticoids) may assist in stabilizing the condition | [106,107] |
Myocardial injury markers | TnT significantly elevated | Troponin test | TnT levels are positively correlated with myocardial necrosis area | - | Early reperfusion therapy reduces peak TnT levels | [108] |
Hemoglobin | Hb, Hct, and RBC were significantly lower than those in the control group | Complete blood count test | Anemia may increase the cardiac workload | - | Blood transfusion support to maintain tissue oxygen supply | [14] |
Cardiac function classification | Killip classification ≥ grade III (78.1% in the deceased group vs 50% in the survival group) | Killip classification assessment | Deterioration of cardiac function is an independent risk factor for mortality | 60 (Killip IV) | IABP support therapy | [25,34] |
Myocardial infarction site | Anterior wall myocardial infarction accounts for 75%-84.6% | ECG, echocardiogram | Anterior wall infarction is prone to involve the blood supply area of the interventricular septum | 75-84.6 | Patients with anterior wall infarction require early screening for VSR | [14,109,110] |
Location of ventricular septal perforation | Near the cardiac apex (anterior wall infarction) vs posterior interventricular septum (inferior wall infarction) | Echocardiography (ventricular septal echo dropout, left-to-right shunt) | Posterior perforation carries a worse prognosis | 60 near the cardiac apex | Interventional closure is suitable for anterior perforations, while surgical repair is indicated for complex locations | [58] |
Perforation diameter | Average 9.8 ± 3.9 mm, large perforation (> 15 mm) are associated with higher mortality rates | Echocardiography | The perforation diameter is positively correlated with the left-to-right shunt volume | - | Major perforations require emergency surgical intervention or occlusion | [10,110] |
Reperfusion therapy | The proportion of reperfusion therapy was low (0% in the death group vs 50% in the survival group) | Coronary angiography (IRA completely occluded) | Failure to receive reperfusion therapy increases the risk of VSR | - | Emergency PCI or thrombolysis reduces the incidence of VSR | [10] |
Comorbidity | Hypertension (60%); Diabetes (27.8%-46.9%) | Medical history collection | Hypertension and diabetes accelerate myocardial remodeling | 60 (hypertension) | Control blood pressure and blood sugar to reduce cardiac workload | [14,110] |
Hemodynamic status | CS (90% mortality group vs 33.9% survival group) | Hemodynamic monitoring (mean arterial pressure, heart rate) | CS is an independent risk factor for 30-day mortality. (OR = 24.112) | 90 (mortality group) | VA-ECMO or IABP | [14] |
Laboratory indicators | Elevated white blood cell count and lactate levels (survival group) | Complete blood count, lactate test | Elevated white blood cell count (OR = 1.619) is associated with mortality | - | Anti-infection and metabolic support therapy | [58] |
MELD-XI Score | Patients with a score > 15 had a 3-year survival rate of 35.7% vs 85.1% for those with a score ≤ 15 | MELD-XI score (Based on creatinine and bilirubin) | High score indicates hepatic and renal dysfunction with poor prognosis | - | Patients with a score > 15 should be prioritized for palliative care | [58] |
Echocardiography parameters | LVEF is normal (66.7% of patients), but cardiac function continues to deteriorate | LVEF, LVEDD measurement | LVEF is normal but mechanical complications are prone to be missed in diagnosis | - | Comprehensive evaluation based on clinical symptoms | [14,93] |
Coronary artery disease | Multivessel disease (62.5%), with the left anterior descending artery being the most common infarct-related vessel | Coronary angiography | Multivessel disease and absence of collateral circulation increase the risk of VSR | 62.5 (multivessel disease) | CABG combined with VSR repair | [14,110] |
Time | Patients with AMI to VSR time ≤ 4 days have higher mortality rates | Medical history review | Early perforation (≤ 4 days) presents fragile myocardial tissue and carries high surgical risks | - | Postpone the surgery for 3-4 weeks (if hemodynamically stable) | [94] |
Timing of surgical intervention | Early surgery (≤ 7 days) mortality rate 43%, delayed surgery (> 4 weeks) mortality rate 65% | Analysis of Surgical Records | The timing of surgery is correlated with myocardial tissue stability | - | Hemodynamically stable patients are recommended for delayed surgery | [111,112] |
Interventional occlusion procedure | The 30-day mortality rate after occlusion was 32%, with a 3-year survival rate of 73.8% | Percutaneous interventional occlusion (umbrella occluder) | Blockage failure is related to the perforation location and diameter | - | Applicable to patients with hemodynamic stability and suitable perforation site | [58] |
Conservative treatment | The mortality rate of conservative treatment was 61.5% vs surgery/intervention at 14.3% | Medications (diuretics, vasodilators, positive inotropic drugs) | Conservative treatment is only suitable for those who cannot tolerate surgery | - | Short-term transitional therapy requires combination with IABP or ECMO | [113] |
Merged ventricular aneurysm | 30% of patients are complicated by ventricular aneurysm | Echocardiography or cardiac MRI | Ventricular aneurysm increases the risk of cardiac rupture | 30 | Resection of ventricular wall aneurysm combined with VSR repair | [21] |
Renal insufficiency | Elevated serum creatinine (death group 138.5 μmol/L vs survival group 88.0 μmol/L) | Serum creatinine test | Renal insufficiency is an independent risk factor for postoperative mortality (OR = 1.78) | - | Preoperative hemofiltration or postoperative CRRT | [14,114] |
Arrhythmia | The incidence of ventricular fibrillation and atrial fibrillation is relatively high | Electrocardiographic monitoring | Arrhythmia reflects instability in myocardial electrical activity | - | Antiarrhythmic drugs or ICDs | [115] |
Thrombosis risk | D-dimer levels were significantly elevated (death group 2.2 μg/mL vs survival group 1.0 μg/mL) | D-dimer test | Hypercoagulability increases the risk of embolism | - | Anticoagulation therapy (such as heparin), but the bleeding risk needs to be balanced | [109,116] |
Pulmonary artery systolic pressure | Pulmonary arterial hypertension (> 50 mmHg) is associated with right heart failure | Echocardiography (Tricuspid Regurgitation Velocity Method) | Pulmonary hypertension indicates increased right heart workload | - | Reduce pulmonary circulation resistance (such as inhaling NO) | [58,117] |
Mitral regurgitation | Mitral regurgitation area shows no significant correlation with mortality | Echocardiography (regurgitant jet area measurement) | Mitral regurgitation is mostly secondary and not an independent risk factor | - | After VSR repair, mitral valve function can be indirectly improved | [118] |
Hospitalization period | The death group had a shorter hospital stay (6 days vs the survival group's 22.5 days) | Medical record analysis | Short-term hospitalization reflects a sharp deterioration in the condition | - | Short-term hospitalization reflects a sharp deterioration in the condition | [6,109] |
Long-term prognosis | 3-year survival rate: Interventional closure 738%, surgical procedure 70% | Follow-up (survival rate, cardiac function classification) | Long-term mortality is often due to heart failure or reinfarction | - | Long-term anti-heart failure therapy postoperatively (such as ARNI, β-blockers) | [6,119] |
Case distribution | VSR accounts for approximately 0.2%-1.57% of AMI | Epidemiological statistics | The incidence of VSR has decreased in the PCI era, but mortality rates remain high | 0.2 - 1.57 | Enhance the popularization rate of early reperfusion therapy to reduce the incidence rate | [98,110] |
- Citation: Zu J, Cheng L, Lu JJ, Xu H, Zhang R, Ye XR, Qiao Q, Zhang LH, Zhang HL, Zhang JJ. Acute myocardial infarction with ventricular septal rupture: Clinical characteristics, prognosis factors, and treatment strategies. World J Cardiol 2025; 17(7): 109787
- URL: https://www.wjgnet.com/1949-8462/full/v17/i7/109787.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i7.109787